Valuation: Unichem Laboratories Limited

Market Cap 20.68B 219M 192M 177M 166M 311M 318M 2.13B 824M 10.22B 823M 805M 35.44B P/E 2024
-48.8x
P/E 2025 35.6x
Enterprise Value 24.38B 258M 227M 209M 196M 367M 374M 2.51B 972M 12.05B 971M 949M 41.79B EV / Sales 2024
2.07x
EV / Sales 2025 2.49x
Free-Float
28.71%
Yield 2024 *
-
Yield 2025 -
1 day-0.13%
1 week-2.54%
Current month+23.94%
1 month+22.13%
3 months+52.44%
6 months-2.76%
Current year-2.00%
1 week 425.5
Extreme 425.5
458
1 month 339.5
Extreme 339.5
515.95
Current year 278.2
Extreme 278.2
515.95
1 year 278.2
Extreme 278.2
657.95
3 years 278.2
Extreme 278.2
937.95
5 years 198
Extreme 198
937.95
10 years 80
Extreme 80
937.95
Manager TitleAgeSince
Chief Executive Officer 57 09/08/2023
Director of Finance/CFO - 07/08/2024
Compliance Officer - -
Director TitleAgeSince
Chairman 73 21/08/1977
Director/Board Member 53 09/08/2023
Director/Board Member 57 09/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-2.54% - - 323M
+7.13%+9.97%+55.80%+160.09% 1,077B
+3.99%+11.50%+67.09%+55.96% 613B
+4.20%+17.03%+38.97%+91.06% 448B
+0.99%+4.85%+28.17%+23.89% 332B
+1.82%+8.19%+40.04%+27.95% 293B
+0.22%+6.75%+31.30%+42.34% 286B
+0.73%+8.53%-27.33%-39.55% 215B
+1.56%+6.14%+29.30%+60.97% 193B
+3.26%+3.33%+15.55%+68.24% 159B
Average +2.38%+8.00%+30.99%+54.55% 401.79B
Weighted average by Cap. +3.85%+8.93%+41.75%+80.17%

Financials

2024 2025
Net sales 17.05B 181M 158M 146M 137M 256M 262M 1.76B 679M 8.43B 679M 664M 29.22B 21.11B 224M 196M 181M 169M 318M 324M 2.17B 841M 10.43B 840M 822M 36.18B
Net income -705M -7.47M -6.55M -6.04M -5.65M -10.6M -10.82M -72.57M -28.08M -348M -28.05M -27.44M -1.21B 1.38B 14.58M 12.78M 11.78M 11.03M 20.68M 21.11M 142M 54.8M 680M 54.74M 53.55M 2.36B
Net Debt 953M 10.1M 8.85M 8.16M 7.64M 14.33M 14.63M 98.1M 37.96M 471M 37.92M 37.09M 1.63B 3.7B 39.24M 34.41M 31.72M 29.69M 55.68M 56.84M 381M 148M 1.83B 147M 144M 6.34B
Logo Unichem Laboratories Limited
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Employees
3,142
Date Price Change Volume
25/06/26 ₹433.00 -0.13% 86,322
24/06/26 ₹433.55 -0.57% 50,042
23/06/26 ₹436.05 -2.63% 100,618
22/06/26 ₹447.85 +0.80% 101,952
19/06/26 ₹444.30 -0.89% 195,599